Date: October 28, 2026
KMP / Board / Auditor Changes
Not Specified
Dividend Declaration or Non-Declaration
Not Specified
Board Meeting Outcomes
- The Board of Directors approved the "Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information" in their meeting held on October 26, 2026
- The Code was formulated under Regulation 8(1) of the SEBI (Prohibition of Insider Trading) Regulations, 2015
Financial Results (Standalone & Consolidated)
Not Specified
Disinvestment / Strategic Actions
Not Specified
Other Operational / Legal / Strategic Disclosures
Regulatory Compliance Disclosure:
- Paras Healthcare Limited disclosed its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) to BSE Limited and National Stock Exchange of India Limited
- The disclosure is made under Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015
- The Code has been made available on the Company's website at https://www.parashospitals.com/investors
- The Code comes into force from the date of listing of the Company's securities on recognized stock exchanges
Code Details:
- Objective: To preserve confidentiality of UPSI and prevent its misuse while ensuring timely and adequate disclosure
- Definitions include: Generally Available Information, Insider, Legitimate Purpose, and Unpublished Price Sensitive Information (UPSI)
- Principles of Fair Disclosure include prompt public disclosure of credible concrete information, uniform dissemination, and addressing market speculations
- The Company Secretary acts as the Chief Investor Relations Officer (CIRO) for dissemination of information and disclosure of UPSI
- UPSI shall be managed exclusively on a "need-to-know" basis for legitimate purposes, professional duties, or legal obligations
Database Maintenance:
- A structured digital database will be maintained containing nature of UPSI and names of persons who shared/received information
- The database will include Permanent Account Numbers or other authorized identifiers
- Database will not be outsourced and will be maintained internally with adequate controls including time stamping and audit trails
- Database will be preserved for at least eight years after completion of relevant transactions
- During SEBI investigations, relevant information will be preserved until completion of proceedings
Legitimate Purpose Criteria:
- Must be shared in ordinary course of business or for corporate purpose
- Required for fiduciary duties or statutory/contractual obligations
- Executed in fair and transparent manner
- In interest of Company or genuine commercial purpose without personal benefit
- Nature of UPSI commensurate with purpose for access